hangzhou tigermed consulti-a
(300347:Shenzhen)
hangzhou tigermed consulti-a (300347) Snapshot
|
Open
CNY50.50
|
Previous Close
CNY50.65
|
|
|
Day High
CNY51.80
|
Day Low
CNY50.30
|
|
|
52 Week High
05/6/13 - CNY60.38
|
52 Week Low
08/16/12 - CNY18.94
|
|
|
Market Cap
5.5B
|
Average Volume 10 Days
2.7M
|
|
|
EPS TTM
CNY0.76
|
Shares Outstanding
106.8M
|
|
|
EX-Date
05/2/13
|
P/E TM
67.6x
|
|
|
Dividend
CNY0.40
|
Dividend Yield
0.78%
|
Related News
hangzhou tigermed consulti-a (300347) Related Businessweek News
No Related Businessweek News Foundhangzhou tigermed consulti-a (300347) Details
Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization in China and internationally. It offers clinical trials services, including biometrics services across various phases of clinical trials in the areas of oncology, endocrinology, CNS, virology, and cardiology. The company provides clinical trial services, such as clinical trial planning, management, and implementation; essential documents preparation; study start-up; site clinical study agreement; monitoring; project management; safety report; QA and QC; and clinical study report writing. It also offers data management services, including CRF design, data management plan development, study database setup and validation, double data entry, computerized edit check, medical coding, discrepancy generation and resolution, blind review and database lock, and neCRF design and EDC system management. In addition, the company provides services in the area of biostatistics, such as statistical considerations and sample size calculation in protocol development; randomization list generation; statistical analysis plan development; SAS programming of statistical tables, listings, and figures; interim analysis; statistical analysis report writing; and final report review by statistician, as well as services in the area of regulatory affairs, including regulatory feasibility study, documents sorting and submission, sample testing arrangement, and IND and NDA tracking. Further, it offers medical translation services comprising handling inter-translations of Chinese, English, Japanese, Korean, and Spanish, as well as provision of written translation and simultaneous translation; and GCP training services for sponsors, research institutions, and clinical research professionals. Hangzhou Tigermed Consulting Co., Ltd. serves pharmaceutical, biopharmaceutical, and medical device companies. The company was founded in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
hangzhou tigermed consulti-a (300347) Key Developments
Hangzhou Tigermed Consulting Co., Ltd. announced that at its first extraordinary general meeting of 2013 held on May 13, 2013, shareholders approved the amendments to the company's articles of association.
Hangzhou Tigermed Consulting Co., Ltd. announced to consider amendments to the company's articles of association at its first extraordinary general meeting of 2013 to be held on May 13, 2013.
Hangzhou Tigermed Consulting Co., Ltd., Special/Extraordinary Shareholders Meeting, May 13, 2013., at 10:00 China Standard Time. Agenda: To consider change of the company's registered capital and amendments to the company's articles of association; and to consider guarantee for joint-stock companies.
| Recently Viewed | |||
| 300347:CH | CNY51.40 CNY | +0.75 | |
| Company | Last | Change |
| PAREXEL International Corp | $46.19 USD | +0.51 |
| WuXi PharmaTech Cayman Inc | $20.89 USD | 0.00 |
| View Industry Companies | ||
Industry Analysis
300347
Industry Average
| Valuation | 300347 | Industry Range |
| Price/Earnings | 65.6x |
|
| Price/Sales | 20.1x |
|
| Price/Book | 7.7x |
|
| Price/Cash Flow | 73.1x |
|
| TEV/Sales | 18.0x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact HANGZHOU TIGERMED CONSULTI-A, please visit www.tigermed.net. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








